.Exelixis is actually giving up on its own tissue aspect (TF)- targeting antibody-drug conjugate aft...
.Three weeks after Roche's Genentech unit left an SHP2 inhibitor pact, Relay Therapy has confirmed t...
.Stoke Therapies' Dravet disorder medication has been actually without a predisposed grip, clearing ...
.Intense Biotech Associate Editor Gabrielle Masson offered the 2024 course of Ferocious 15 winners o...
.Novo Nordisk has axed its own once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) advanceme...
.Merck & Co. has actually rapidly redeemed a number of the prices of its Weapon Therapies buyout,...
.After BioMarin administered a springtime clean of its own pipeline in April, the firm has actually ...
.Huge Pharmas remain caught to the tip of molecular glue degraders. The most recent company to find ...
.A brand-new worldwide lifestyle science credit scores firm, nicknamed Symbiotic Funds, has increase...
.Bristol Myers Squibb is actually axing an additional large bet from the Caforio era, canceling a pa...